Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.
Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.
复制标题
DOI:
10.1126/scisignal.aaf0626
复制
发表时间:
2016-07-26
影响因子:
7.3
通讯作者:
Wucherpfennig KW
中科院分区:
文献类型:
--
作者:
Dobbins J;Gagnon E;Godec J;Pyrdol J;Vignali DA;Sharpe AH;Wucherpfennig KW
The T cell costimulatory receptor CD28 is required for the full activation of naïve T cells and for the development and maintenance of Foxp3+ regulatory T (Treg) cells. We showed that the cytoplasmic domain of CD28 was bound to the plasma membrane in resting cells and that ligand binding to CD28 resulted in its release. Membrane binding by the CD28 cytoplasmic domain required two clusters of basic amino acid residues, which interacted with the negatively charged inner leaflet of the plasma membrane. These same clusters of basic residues also served as interaction sites for Lck, a Src family kinase critical for CD28 function. This signaling complex was further stabilized by the Lck-mediated phosphorylation of CD28 Tyr207 and the subsequent binding of the Src homology 2 (SH2) domain of Lck to this phosphorylated tyrosine. Mutation of the basic clusters in the CD28 cytoplasmic domain reduced the recruitment to the CD28-Lck complex of protein kinase Cθ (PKCθ), which serves as a key effector kinase in the CD28 signaling pathway. Consequently, mutation of either a basic cluster or Tyr207 impaired CD28 function in mice as shown by the reduced thymic differentiation of FoxP3+ Treg cells. On the basis of these results, we propose a previously un-described model for the initiation of CD28 signaling.
登录
查看更多内容
DOI:
10.1084/jem.20052230
发表时间:
2006-09-04
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Friend LD;Shah DD;Deppong C;Lin J;Bricker TL;Juehne TI;Rose CM;Green JM
通讯作者:
Green JM
影响因子:
11.4
作者:
BIFFEN, M;MCMICHAELPHILLIPS, D;ALEXANDER, D
通讯作者:
ALEXANDER, D
DOI:
10.1084/jem.190.3.375
发表时间:
1999-08-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Holdorf AD;Green JM;Levin SD;Denny MF;Straus DB;Link V;Changelian PS;Allen PM;Shaw AS
通讯作者:
Shaw AS
影响因子:
30.5
作者:
Irles, C;Symons, A;Acuto, O
通讯作者:
Acuto, O
影响因子:
30.5
作者:
Kong, Kok-Fai;Yokosuka, Tadashi;Canonigo-Balancio, Ann J.;Isakov, Noah;Saito, Takashi;Altman, Amnon
通讯作者:
Altman, Amnon